Scientific Reports · 2017 · 75 citations · 42 references
Life SciencesGeneticsMolecular GeneticsGenetic EngineeringGenome EditingGenomicsCrispr-based EngineeringCrispr-cas SystemsGenome RearrangementMutagenesis StrategiesTherapeutic Genome EditingCrispr-based Genome EngineeringCrispr-cas9 Genome EditingCrispr-cas9 KnockoutCrispr-cas9 Knockout ModelsCrispr-cas9-mediated Repair
Modelling Down syndrome (DS) in mouse has been crucial for the understanding of the disease and the evaluation of therapeutic targets. Nevertheless, the modelling so far has been limited to the mouse and, even in this model, generating duplication of genomic regions has been labour intensive and time consuming. We developed the CRISpr MEdiated REarrangement (CRISMERE) strategy, which takes advantage of the CRISPR/Cas9 system, to generate most of the desired rearrangements from a single experiment at much lower expenses and in less than 9 months. Deletions, duplications, and inversions of genomic regions as large as 24.4 Mb in rat and mouse founders were observed and germ line transmission was confirmed for fragment as large as 3.6 Mb. Interestingly we have been able to recover duplicated regions from founders in which we only detected deletions. CRISMERE is even more powerful than anticipated it allows the scientific community to manipulate the rodent and probably other genomes in a fast and efficient manner which was not possible before.
42
Chromosome engineering in mice
Ramiro Ramírez‐Solis, Pentao Liu, Allan Bradley · Nature · 1995 · 476 citations
Life Sciences, Biology, Genetics +8
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
Joseph D. Growney, Hirokazu Shigematsu, Zhe Li et al. · Blood · 2005 · 453 citations · Full text
Life Sciences, Genetics, Hematology +14
Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours
Angeliki Malliri, Rob A. van der Kammen, Kristopher Clark et al. · Nature · 2002 · 385 citations
Medicine, Cancer Biology, Oncology +16